Raptor Pharmaceutical (RPTP +1.1%) says its Procysbi delayed-release capsules for the treatment...

|About: Raptor Pharmaceutical Corp. (RPTP)|By:, SA News Editor

Raptor Pharmaceutical (RPTP +1.1%) says its Procysbi delayed-release capsules for the treatment of nephropathic cystinosis are now available in the U.S. for shipment. Nephropathic cystinosis is a rare, life-threatening metabolic lysosomal storage disorder that causes toxic accumulation of cystine in all cells, tissues, and organs in the body.